The analyst says his more bullish view on Siris reflects continued improvement in U.S. auto sales and evidence that a precent price hike is not affecting churn, retention and discounting as much as he had feared.
"Many patients called into their doctors with a sense of deep anxiety, and it is possible that many people stopped a needed drug based on media hype about an unproven and even highly questionable finding, " says Ethel Siris, M.